Merck Manual

Please confirm that you are not located inside the Russian Federation

Yes No
Leave this Site?

The link you have selected will take you to a third-party website. We do not control or have responsibility for the content of any third-party site.

Continue Cancel
honeypot link
Merck Manual
Consumer Version
The trusted provider of medical information since 1899
VIEW PROFESSIONAL VERSION
VIEW PROFESSIONAL VERSION
Health Topics & Chapters
Risk Factors for Developing Opportunistic Fungal Infections

Risk Factors for Developing Opportunistic Fungal Infections

Use of drugs that suppress the immune system

  • Cancer chemotherapy drugs

  • Corticosteroids

  • Drugs to prevent rejection of an organ transplant, such as azathioprine, methotrexate, and cyclosporine

  • Tumor necrosis factor inhibitors (used to treat rheumatoid arthritis and related disorders)

Disorders

Brought to you by Merck & Co, Inc., Rahway, NJ, USA (known as MSD outside the US and Canada)—dedicated to using leading-edge science to save and improve lives around the world. Learn more about the Merck Manuals and our commitment to Global Medical Knowledge.


This icon serves as a link to download the eSSENTIAL Accessibility assistive technology app for individuals with physical disabilities. It is featured as part of our commitment to diversity and inclusion. M
This icon serves as a link to download the eSSENTIAL Accessibility assistive technology app for individuals with physical disabilities. It is featured as part of our commitment to diversity and inclusion. M
View Privacy Shield Verification Status
View APEC CBPR Privacy Certification Status

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.